POLYTHERAPIE DE CANCERS CHIMIORESISTANTS

• 收藏
• 分享

专利权人:

THE REGENTS OF THE UNIVERSITY OF CALIFORNIA

发明人:

KIPPS, THOMAS,ZHANG, SUPING,GHIA, EMANUELA M.

申请号：

CA3093568

公开号：

CA3093568A1

申请日:

2019.03.11

申请国别(地区):

CA

年份:

2019

代理人:

摘要：

There are provided, inter alia, compositions and methods for treatment of chemoresistant cancer (breast cancer). The methods include administering to a subject in need a therapeutically effective amount of a chemotherapeutic agent and a ROR- 1 antagonist. Further provided are pharmaceutical compositions including chemotherapeutic agent, ROR- 1 antagonist and a pharmaceutically acceptable excipient. In embodiments, the chemotherapeutic agent is paclitaxel and the ROR- 1 antagonist is cirmtuzumab.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/